Research location
Santiago
Providencia, Chile
Advertisement
Research activity in Santiago
Providencia, ChileCureCurrent currently publishes aggregate city-level research activity for this location: 8 trials and 8 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Santiago
8 linked trials · page 1 of 1PRECAMA: Molecular Subtypes of Premenopausal Breast Cancer in Latin American WomenNCT03144648 · 2012-10-12 · 1 site observation
RECRUITING
A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With SurgeryNCT06161441 · 2024-07-16 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's SyndromeNCT05946941 · 2023-09-11 · 1 site observation
ACTIVE_NOT_RECRUITING
Effect of Periodontal Treatment on Metabolic Control in Patients with Type-2 Diabetes Mellitus Treated in the Cardiovascular Healt ProgramNCT06895980 · 2023-08-22 · 1 site observation
UNKNOWN
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)NCT05813288 · 2023-03-27 · 1 site observation
TERMINATED
Evaluation and Implementation of an mHealth Intervention Called Mami-educ to Fight Against Gestational ObesityNCT05114174 · 2022-01-03 · 1 site observation
COMPLETED
Abatacept Versus Adalimumab Head-to-HeadNCT00929864 · 2009-10-01 · 1 site observation
COMPLETED
Study of Rivoglitazone in Type 2 Diabetes MellitusNCT00484198 · 2007-04-23 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.